" class="no-js "lang="en-US"> Ewa Weglinska, Avery Dennison, on Pharmaceutical Sustainability
Friday, March 31, 2023

Breaking News

Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Hansa Biopharma Completes Enrollment in Phase 2 Study of Imlifidase in Guillain-Barré Syndrome (GBS) ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment NADclinic Group, BioStarks and Do Not Age Announce Exclusive Partnership to Revolutionise Personalised Longevity PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics

February 21 2023

Ewa Weglinska, Avery Dennison, on Sustainability in the Pharmaceutical Industry

In the video, Ewa Weglinska, Product Manager Pharmaceuticals, at Avery Dennison, talks about the importance of sustainability in packaging for pharmaceutical products.

She highlights the challenges faced by the industry, such as the need for enabling recyclability, as well as the increasing demand for environmentally friendly options. Weglinska discusses various sustainable packaging solutions, such as using renewable materials and optimizing packaging design to reduce waste.

She also emphasizes the importance of collaboration between different stakeholders in the industry to achieve sustainability goals. Overall, the video provides valuable insights into the efforts being made to promote sustainable packaging in the pharmaceutical industry.

  1. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions

    Appointments

     Read more
  2. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board

    Appointments

     Read more
  3. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China

    Diseases

     Read more
  4. Hansa Biopharma Completes Enrollment in Phase 2 Study of Imlifidase in Guillain-Barré Syndrome (GBS)

    Clinical Trials

     Read more
  5. ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment

    Drug Development

     Read more
More On